Akari Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:AKTX Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Role	Shares	Max Price
29 Dec 23	BuyUS$1,000,001	Raymond Prudo-Chlebosz	Individual		473,934	US$2.11

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 338%.

Top 25 shareholders own 106.08% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
32.7%	Hoyoung Huh	3,912,454	US$9.2m	0%	no data
20.5%	Samir Patel	2,453,757	US$5.8m	-29%	no data
15.3%	Raymond Prudo-Chlebosz	1,828,919	US$4.3m	0%	no data
8.88%	Matthew Nachtrab	1,061,007	US$2.5m	0%	no data
8.88%	Charles Theofilos	1,061,007	US$2.5m	0%	no data
7.9%	Thomas Mollick	944,910	US$2.2m	0%	no data
4.28%	Sandip Patel	512,107	US$1.2m	0%	no data
3.35%	RPC Pharma Limited	400,383	US$945.4k	0%	no data
1.74%	Rachelle Jacques	207,642	US$490.3k	234%	no data
0.73%	Omnia Family Wealth, LLC	87,628	US$206.9k	0%	0.05%
0.28%	Citadel Advisors LLC	33,260	US$78.5k	0%	no data
0.2%	Cerity Partners LLC	23,643	US$55.8k	0%	no data
0.16%	Praxis Group, Asset Management Arm	19,355	US$45.7k	0%	100.0%
0.16%	Sonic Healthcare Holding Company	19,355	US$45.7k	0%	no data
0.15%	Cresset Asset Management, LLC	18,408	US$43.5k	0%	no data
0.15%	Renaissance Technologies LLC	18,069	US$42.7k	5.86%	no data
0.093%	James Neal	11,108	US$26.2k	0%	no data
0.084%	Donald Williams	10,000	US$23.6k	0%	no data
0.084%	Donald Williams	10,000	US$23.6k	0%	no data
0.084%	James Hill	10,000	US$23.6k	0%	no data
0.084%	Stuart Ungar	10,000	US$23.6k	0%	no data
0.084%	David Byrne	10,000	US$23.6k	0%	no data
0.084%	Michael Grissinger	10,000	US$23.6k	0%	no data
0.051%	Bg Fund Management Luxembourg S.A.	6,114	US$14.4k	0%	no data
0.013%	Geode Capital Management, LLC	1,512	US$3.6k	-3.2%	no data